{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:00:06Z","timestamp":1790776806405,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.alit.2026.02.005","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T12:57:21Z","timestamp":1773320241000},"page":"549-561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dual clinical remission in patients treated with biologics for severe asthma and eosinophilic chronic rhinosinusitis"],"prefix":"10.1016","volume":"75","author":[{"given":"Naoko","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Numata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keitaro","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanae","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saburo","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Minagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyoshi","family":"Otori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Araya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2026.02.005_bib1","series-title":"Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach","first-page":"1","year":"2007"},{"key":"10.1016\/j.alit.2026.02.005_bib2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jaci.2014.08.042","article-title":"The prevalence of severe refractory asthma","volume":"135","author":"Hekking","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2026.02.005_bib3","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0238-2023","article-title":"Biologic agents licensed for severe asthma: a systematic review and meta-analysis of randomised controlled trials","volume":"33","author":"Kyriakopoulos","year":"2024","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.alit.2026.02.005_bib4","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1111\/all.14620","article-title":"Adult-onset eosinophilic airway diseases","volume":"75","author":"Asano","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2026.02.005_bib5","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jaci.2023.06.005","article-title":"Eosinophils and tissue remodeling: relevance to airway disease","volume":"152","author":"Siddiqui","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2026.02.005_bib6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12890-019-0952-1","article-title":"Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis","volume":"19","author":"Numata","year":"2019","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.alit.2026.02.005_bib7","first-page":"1","article-title":"Clinical remission attainment, definitions and correlates among biologic-treated patients with severe asthma: a systematic review and meta-analysis","volume":"2600","author":"Shackleford","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.alit.2026.02.005_bib8","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2147\/JAA.S311975","article-title":"Effectiveness of switching biologics for severe asthma patients in Japan: a single-center retrospective study","volume":"14","author":"Numata","year":"2021","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.alit.2026.02.005_bib9","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.alit.2026.02.005_bib10","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S2213-2600(21)00097-7","article-title":"Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Han","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.alit.2026.02.005_bib11","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1056\/NEJMoa2414482","article-title":"Tezepelumab in adults with severe chronic rhinosinusitis with nasal polyps","volume":"392","author":"Lipworth","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.alit.2026.02.005_bib12","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/all.12644","article-title":"Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC study","volume":"70","author":"Tokunaga","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2026.02.005_bib13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.alit.2020.08.001","article-title":"Japanese guidelines for adult asthma 2020","volume":"69","author":"Nakamura","year":"2020","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2026.02.005_bib14","series-title":"Global strategy for asthma management and prevention","year":"2024"},{"key":"10.1016\/j.alit.2026.02.005_bib15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.alit.2021.02.002","article-title":"Cycling therapy with benralizumab and dupilumab for severe eosinophilic asthma with eosinophilic chronic rhinosinusitis and eosinophilic otitis media","volume":"70","author":"Hamada","year":"2021","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2026.02.005_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.alit.2025.11.004","article-title":"Consensus definition of clinical remission in asthma for the Japanese asthma prevention and management guidelines (JGL 2024): a modified Delphi survey and comprehensive review","volume":"75","author":"Nagase","year":"2026","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2026.02.005_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.103050","article-title":"Roads to remission: evolving treatment concepts in type 2 inflammatory diseases","volume":"80","author":"Lommatzsch","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.alit.2026.02.005_bib18","first-page":"287","article-title":"EPOS2020\/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP","volume":"62","author":"Fokkens","year":"2024","journal-title":"Rhinology"},{"key":"10.1016\/j.alit.2026.02.005_bib19","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2026.02.005_bib20","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s12325-025-03120-y","article-title":"Real-world outcomes following biologic initiation in US patients with chronic rhinosinusitis with nasal polyps","volume":"42","author":"Peters","year":"2025","journal-title":"Adv Ther"},{"key":"10.1016\/j.alit.2026.02.005_bib21","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1007\/s00405-025-09619-y","article-title":"Remission in chronic rhinosinusitis with nasal polyps treated with biologics: a real-life experience","volume":"282","author":"Loperfido","year":"2025","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.alit.2026.02.005_bib22","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.3390\/biom12101456","article-title":"Immunosenescence, inflammaging, and lung senescence in asthma in the elderly","volume":"12","author":"Soma","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.alit.2026.02.005_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104717","article-title":"Cellular senescence in asthma: from pathogenesis to therapeutic challenges","volume":"94","author":"Wan","year":"2023","journal-title":"eBioMedicine"},{"key":"10.1016\/j.alit.2026.02.005_bib24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1164\/rccm.201807-1291OC","article-title":"A transcriptomic method to determine airway immune dysfunction in T2-high and T2-low asthma","volume":"199","author":"Peters","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2026.02.005_bib25","article-title":"Identification of biologic-responsive phenotypes in elderly people with eosinophilic asthma","volume":"3","author":"Prokunina","year":"2023","journal-title":"J Allergy Clin Immunol Glob"},{"key":"10.1016\/j.alit.2026.02.005_bib26","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.chest.2024.11.045","article-title":"The role of bronchial biopsy in the prediction of response to biologic therapy in severe uncontrolled asthma: a prospective study","volume":"167","author":"Cos\u00edo","year":"2025","journal-title":"Chest"},{"key":"10.1016\/j.alit.2026.02.005_bib27","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.alit.2024.02.002","article-title":"Efficacy of dupilumab for airway hypersecretion and airway wall thickening in patients with moderate-to-severe asthma: a prospective, observational study","volume":"73","author":"Tajiri","year":"2024","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2026.02.005_bib28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jaci.2024.10.024","article-title":"Effect of mepolizumab in airway remodeling in patients with late-onset severe asthma with an eosinophilic phenotype","volume":"155","author":"Domvri","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2026.02.005_bib29","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.resinv.2021.02.009","article-title":"Efficacy of mepolizumab in elderly patients with severe asthma and overlapping COPD in real-world settings: a retrospective observational study","volume":"59","author":"Isoyama","year":"2021","journal-title":"Respir Investig"},{"key":"10.1016\/j.alit.2026.02.005_bib30","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00819-2023","article-title":"Clinical remission in severe asthma with biologic therapy: an analysis from the UK severe asthma registry","volume":"62","author":"McDowell","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2026.02.005_bib31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.chest.2023.10.046","article-title":"Clinical response and remission in patients with severe asthma treated with biologic therapies","volume":"165","author":"Hansen","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.alit.2026.02.005_bib32","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1165\/rcmb.2015-0207RC","article-title":"Age-related increased prevalence of asthma and nasal polyps in chronic rhinosinusitis and its association with altered IL-6 trans-signaling","volume":"53","author":"Cho","year":"2015","journal-title":"Am J Respir Cel Mol Biol"},{"key":"10.1016\/j.alit.2026.02.005_bib33","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2147\/JAA.S517258","article-title":"Impact of comorbid asthma on life quality of patients with chronic rhinosinusitis and nasal polyps","volume":"18","author":"Wu","year":"2025","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.alit.2026.02.005_bib34","article-title":"Impact of chronic rhinosinusitis on severe asthma patients","volume":"12","author":"Lee","year":"2017","journal-title":"PLOS ONE"},{"key":"10.1016\/j.alit.2026.02.005_bib35","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/j.jaip.2024.05.016","article-title":"Exploring definitions and predictors of response to biologics for severe asthma","volume":"12","author":"Scelo","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2026.02.005_bib36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.resinv.2025.02.003","article-title":"Eosinophilic chronic rhinosinusitis as a predictor of super-responder and clinical remission in patients with uncontrolled type 2-high severe asthma treated with biologics","volume":"63","author":"Hamada","year":"2025","journal-title":"Respir Investig"},{"key":"10.1016\/j.alit.2026.02.005_bib37","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1016\/j.jaip.2024.08.033","article-title":"Long-term clinical and sustained REMIssion in severe eosinophilic asthma treated with mepolizumab: the REMI-M study","author":"Crimi","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2026.02.005_bib38","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/all.15067","article-title":"Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: results from two randomized placebo-controlled phase 3 trials","volume":"77","author":"Mullol","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2026.02.005_bib39","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.jaip.2023.04.054","article-title":"The management of chronic rhinosinusitis with nasal polyps (CRSwNP) with biologics","volume":"11","author":"Wautlet","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2026.02.005_bib40","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaci.2021.05.043","article-title":"Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease","volume":"148","author":"Buchheit","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2026.02.005_bib41","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01335-2022","article-title":"Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease","volume":"61","author":"Schneider","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2026.02.005_bib42","article-title":"Lung function impairment and eosinophilia in patients with eosinophilic chronic rhinosinusitis","volume":"4","author":"Sonoda","year":"2025","journal-title":"J Allergy Clin Immunol Glob"},{"key":"10.1016\/j.alit.2026.02.005_bib43","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.alit.2023.08.004","article-title":"Relationship between aspergillus and asthma","volume":"72","author":"Agarwal","year":"2023","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2026.02.005_bib44","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/all.12230","article-title":"Staphylococcus aureus enterotoxin-specific IgE is associated with asthma in the general population: a GA2LEN study","volume":"68","author":"Tomassen","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2026.02.005_bib45","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/cea.13680","article-title":"Fungal sensitization and its relationship to mepolizumab response in patients with severe eosinophilic asthma","volume":"50","author":"Wardlaw","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2026.02.005_bib46","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.jaip.2021.02.048","article-title":"Real-world effectiveness of Anti\u2013IL-5\/5R therapy in severe atopic eosinophilic asthma with fungal sensitization","volume":"9","author":"Dhariwal","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2026.02.005_bib47","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/cea.14389","article-title":"Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitization","volume":"53","author":"Corren","year":"2023","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2026.02.005_bib48","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2222.2010.03584.x","article-title":"Role of fungal antigens in eosinophilia-associated cellular responses in nasal polyps: a comparison with enterotoxin","volume":"41","author":"Okano","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2026.02.005_bib49","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/cea.13557","article-title":"Clinical relevance of Aspergillus fumigatus sensitization in cystic fibrosis","volume":"50","author":"Eickmeier","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2026.02.005_bib50","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41584-023-00958-w","article-title":"Evidence-based guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis","volume":"19","author":"Emmi","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.alit.2026.02.005_bib51","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S2213-2600(21)00097-7","article-title":"Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Han","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.alit.2026.02.005_bib52","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jaci.2021.08.030","article-title":"Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: a randomized, placebo-controlled trial","volume":"149","author":"Bachert","year":"2022","journal-title":"J Allergy Clin Immunol"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893026000201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893026000201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:28:08Z","timestamp":1790774888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893026000201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1323893026000201"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2026.02.005","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual clinical remission in patients treated with biologics for severe asthma and eosinophilic chronic rhinosinusitis","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2026.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Japanese Society of Allergology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}